Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Enliven Therapeutics, Inc. (ELVN) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Enliven Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1672619.
Total stock buying since 2020: $105,368,741.
Total stock sales since 2020: $97,141,123.
Total stock option exercises since 2020: $2,198,969.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 256,519 | $5,339,567 | 64,700 | $150,625 |
| 2024 | 0 | $0 | 2,782,453 | $62,544,973 | 433,420 | $1,891,769 |
| 2023 | 32,380 | $177,203 | 4,552,864 | $26,732,320 | 103,867 | $134,676 |
| 2022 | 1,568,996 | $3,591,548 | 1,017,890 | $1,519,495 | 0 | $0 |
| 2021 | 4,666,665 | $27,999,990 | 358,579 | $848,518 | 0 | $0 |
| 2020 | 4,600,000 | $73,600,000 | 6,250 | $156,250 | 6,250 | $21,899 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 33,400 | $658,922 | 3,250 | $8,060 |
| 2025-07 | 0 | $0 | 35,917 | $789,386 | 4,250 | $10,540 |
| 2025-06 | 0 | $0 | 52,917 | $1,123,244 | 6,250 | $15,500 |
| 2025-05 | 0 | $0 | 34,917 | $645,321 | 3,250 | $8,060 |
| 2025-04 | 0 | $0 | 19,917 | $348,429 | 3,250 | $8,060 |
| 2025-03 | 0 | $0 | 35,917 | $752,660 | 14,250 | $35,340 |
| 2025-02 | 0 | $0 | 10,917 | $235,057 | 4,250 | $10,540 |
| 2025-01 | 0 | $0 | 32,617 | $786,548 | 25,950 | $54,525 |
| 2024-12 | 0 | $0 | 4,250 | $94,474 | 17,250 | $42,780 |
| 2024-11 | 0 | $0 | 5,250 | $131,659 | 5,250 | $13,020 |
| 2024-10 | 0 | $0 | 145,801 | $4,103,695 | 30,309 | $180,614 |
| 2024-09 | 0 | $0 | 7,520 | $182,286 | 6,250 | $15,500 |
| 2024-08 | 0 | $0 | 29,520 | $673,420 | 4,250 | $10,540 |
| 2024-07 | 0 | $0 | 104,231 | $2,642,726 | 9,241 | $22,917 |
| 2024-06 | 0 | $0 | 18,653 | $409,582 | 5,383 | $13,349 |
| 2024-05 | 0 | $0 | 2,103,362 | $46,599,835 | 35,492 | $55,379 |
| 2024-04 | 0 | $0 | 254,020 | $5,907,780 | 239,584 | $1,363,167 |
| 2024-03 | 0 | $0 | 34,673 | $621,121 | 28,528 | $94,794 |
| 2024-02 | 0 | $0 | 21,395 | $351,287 | 15,250 | $21,500 |
| 2024-01 | 0 | $0 | 53,778 | $827,108 | 36,633 | $58,209 |
| 2023-12 | 0 | $0 | 67,166 | $926,393 | 59,045 | $71,046 |
| 2023-11 | 0 | $0 | 16,572 | $216,743 | 16,572 | $18,560 |
| 2023-09 | 0 | $0 | 221,500 | $3,291,696 | 24,000 | $26,880 |
| 2023-08 | 0 | $0 | 440,000 | $7,040,000 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 3,250 | 20.63 | 67,037 |
| 2025-08-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 3,250 | 2.48 | 8,060 |
| 2025-08-21 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 7,500 | 20.01 | 150,097 |
| 2025-08-19 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 590 | 20.00 | 11,800 |
| 2025-08-19 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 5,000 | 19.62 | 98,120 |
| 2025-08-18 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 10,393 | 20.02 | 208,109 |
| 2025-08-07 | Patel Anish (CHIEF OPERATING OFFICER) | Sale | 6,667 | 18.56 | 123,759 |
| 2025-07-28 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 3,250 | 20.87 | 67,837 |
| 2025-07-28 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 3,250 | 2.48 | 8,060 |
| 2025-07-21 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 12,500 | 22.58 | 282,237 |
| 2025-07-17 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 12,500 | 22.55 | 281,837 |
| 2025-07-10 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 1,000 | 22.66 | 22,655 |
| 2025-07-10 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 1,000 | 2.48 | 2,480 |
| 2025-07-07 | Patel Anish (CHIEF OPERATING OFFICER) | Sale | 6,667 | 20.22 | 134,820 |
| 2025-06-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 3,250 | 21.26 | 69,095 |
| 2025-06-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 3,250 | 2.48 | 8,060 |
| 2025-06-20 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 12,500 | 21.40 | 267,462 |
| 2025-06-17 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 12,500 | 22.41 | 280,162 |
| 2025-06-13 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 3,000 | 22.55 | 67,656 |
| 2025-06-13 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 3,000 | 2.48 | 7,440 |
| 2025-06-09 | Patel Anish (CHIEF OPERATING OFFICER) | Sale | 6,667 | 20.74 | 138,300 |
| 2025-06-03 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 7,500 | 20.05 | 150,352 |
| 2025-06-03 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 7,500 | 20.03 | 150,217 |
| 2025-05-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 3,250 | 16.18 | 52,594 |
| 2025-05-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 3,250 | 2.48 | 8,060 |
| 2025-05-19 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 5,000 | 16.49 | 82,455 |
| 2025-05-19 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 5,000 | 16.31 | 81,535 |
| 2025-05-07 | Patel Anish (CHIEF OPERATING OFFICER) | Sale | 6,667 | 19.19 | 127,933 |
| 2025-05-02 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 2,170 | 20.00 | 43,408 |
| 2025-05-02 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 2,470 | 20.01 | 49,424 |
| 2025-05-01 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 5,330 | 20.08 | 107,005 |
| 2025-05-01 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 5,030 | 20.07 | 100,967 |
| 2025-04-28 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 3,250 | 18.90 | 61,418 |
| 2025-04-28 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 3,250 | 2.48 | 8,060 |
| 2025-04-21 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 5,000 | 16.37 | 81,870 |
| 2025-04-17 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 5,000 | 16.42 | 82,095 |
| 2025-04-07 | Patel Anish (CHIEF OPERATING OFFICER) | Sale | 6,667 | 18.46 | 123,046 |
| 2025-03-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 3,250 | 21.33 | 69,322 |
| 2025-03-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 3,250 | 2.48 | 8,060 |
| 2025-03-24 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 1,000 | 22.50 | 22,505 |
| 2025-03-24 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 1,000 | 2.48 | 2,480 |
| 2025-03-19 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 12,500 | 20.61 | 257,575 |
| 2025-03-17 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 12,500 | 20.83 | 260,325 |
| 2025-03-07 | Patel Anish (CHIEF OPERATING OFFICER) | Sale | 6,667 | 21.44 | 142,933 |
| 2025-03-04 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 10,000 | 2.48 | 24,800 |
| 2025-02-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 3,250 | 20.41 | 66,326 |
| 2025-02-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 3,250 | 2.48 | 8,060 |
| 2025-02-07 | Patel Anish (CHIEF OPERATING OFFICER) | Sale | 6,667 | 21.93 | 146,207 |
| 2025-02-05 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 1,000 | 22.52 | 22,524 |
| 2025-02-05 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 1,000 | 2.48 | 2,480 |
| 2025-01-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 3,250 | 21.59 | 70,177 |
| 2025-01-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 3,250 | 2.48 | 8,060 |
| 2025-01-07 | Patel Anish (CHIEF OPERATING OFFICER) | Sale | 28,367 | 24.37 | 691,332 |
| 2025-01-07 | Patel Anish (CHIEF OPERATING OFFICER) | Option Ex | 21,700 | 2.03 | 43,985 |
| 2025-01-03 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 1,000 | 25.04 | 25,039 |
| 2025-01-03 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 1,000 | 2.48 | 2,480 |
| 2024-12-30 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 900 | 22.51 | 20,255 |
| 2024-12-30 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 900 | 2.48 | 2,232 |
| 2024-12-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 3,350 | 22.16 | 74,219 |
| 2024-12-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 3,350 | 2.48 | 8,308 |
| 2024-12-13 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 13,000 | 2.48 | 32,240 |
| 2024-11-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 5,250 | 25.08 | 131,659 |
| 2024-11-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 5,250 | 2.48 | 13,020 |
| 2024-10-28 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 6,250 | 28.80 | 180,012 |
| 2024-10-28 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 6,250 | 2.48 | 15,500 |
| 2024-10-18 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 924 | 30.00 | 27,722 |
| 2024-10-18 | Patel Anish (CHIEF OPERATING OFFICER) | Sale | 716 | 30.00 | 21,482 |
| 2024-10-18 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 847 | 30.00 | 25,412 |
| 2024-10-18 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 814 | 30.00 | 24,422 |
| 2024-10-18 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 814 | 2.48 | 2,018 |
| 2024-10-18 | Collins Helen Louise (CHIEF MEDICAL OFFICER) | Sale | 816 | 30.00 | 24,482 |
| 2024-10-18 | Collins Helen Louise (CHIEF MEDICAL OFFICER) | Option Ex | 816 | 2.48 | 2,023 |
| 2024-10-18 | Heyman Richard A. | Sale | 1,570 | 30.00 | 47,104 |
| 2024-10-15 | Heyman Richard A. | Sale | 1,270 | 27.67 | 35,143 |
| 2024-10-09 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 16,710 | 28.30 | 472,909 |
| 2024-10-09 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 37,878 | 28.32 | 1,072,704 |
| 2024-10-08 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 13,267 | 28.23 | 374,553 |
| 2024-10-08 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 13,267 | 28.24 | 374,607 |
| 2024-10-08 | Ballal Rahul D. | Sale | 10,420 | 28.17 | 293,562 |
| 2024-10-08 | Ballal Rahul D. | Option Ex | 10,420 | 12.60 | 131,292 |
| 2024-10-07 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 2,730 | 27.50 | 75,075 |
| 2024-10-07 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 2,707 | 27.61 | 74,726 |
| 2024-10-07 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 1,270 | 27.51 | 34,935 |
| 2024-10-07 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 1,270 | 2.48 | 3,149 |
| 2024-10-04 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 12,206 | 27.51 | 335,787 |
| 2024-10-04 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 7,522 | 27.51 | 206,937 |
| 2024-10-04 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 10,218 | 27.51 | 281,076 |
| 2024-10-04 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 10,218 | 2.48 | 25,340 |
| 2024-10-04 | Heyman Richard A. | Sale | 2,825 | 27.51 | 77,704 |
| 2024-10-01 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 526 | 27.54 | 14,484 |
| 2024-10-01 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 527 | 27.54 | 14,511 |
| 2024-10-01 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 521 | 27.54 | 14,346 |
| 2024-10-01 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 521 | 2.48 | 1,292 |
| 2024-09-30 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 2,000 | 25.33 | 50,668 |
| 2024-09-30 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 2,000 | 2.48 | 4,960 |
| 2024-09-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 4,250 | 24.27 | 103,160 |
| 2024-09-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 4,250 | 2.48 | 10,540 |
| 2024-09-16 | Heyman Richard A. | Sale | 1,270 | 22.41 | 28,458 |
| 2024-08-29 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 12,000 | 22.78 | 273,384 |
| 2024-08-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 4,250 | 22.54 | 95,782 |
| 2024-08-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 4,250 | 2.48 | 10,540 |
| 2024-08-26 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 12,000 | 22.89 | 274,716 |
| 2024-08-15 | Heyman Richard A. | Sale | 1,270 | 23.26 | 29,538 |
| 2024-07-31 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 2,270 | 27.56 | 62,554 |
| 2024-07-31 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 3,099 | 27.56 | 85,399 |
| 2024-07-31 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 991 | 27.53 | 27,281 |
| 2024-07-31 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 991 | 2.48 | 2,457 |
| 2024-07-31 | Heyman Richard A. | Sale | 2,351 | 27.50 | 64,659 |
| 2024-07-29 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 12,000 | 27.06 | 324,708 |
| 2024-07-29 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 5,250 | 27.05 | 142,038 |
| 2024-07-29 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 5,250 | 2.48 | 13,020 |
| 2024-07-25 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 12,000 | 25.15 | 301,836 |
| 2024-07-16 | Patel Anish (CHIEF OPERATING OFFICER) | Sale | 1,547 | 25.01 | 38,692 |
| 2024-07-15 | Patel Anish (CHIEF OPERATING OFFICER) | Sale | 30,978 | 25.05 | 776,029 |
| 2024-07-15 | Heyman Richard A. | Sale | 1,270 | 24.80 | 31,497 |
| 2024-07-12 | Patel Anish (CHIEF OPERATING OFFICER) | Sale | 17,475 | 25.07 | 438,098 |
| 2024-07-12 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 3,000 | 25.07 | 75,195 |
| 2024-07-12 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 3,000 | 2.48 | 7,440 |
| 2024-07-01 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 12,000 | 22.89 | 274,740 |
| 2024-06-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 4,250 | 22.60 | 96,050 |
| 2024-06-27 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 4,250 | 2.48 | 10,540 |
| 2024-06-25 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 12,000 | 21.96 | 263,532 |
| 2024-06-17 | Heyman Richard A. | Sale | 1,270 | 21.48 | 27,278 |
| 2024-06-06 | Patel Anish (CHIEF OPERATING OFFICER) | Sale | 1,133 | 20.05 | 22,722 |
| 2024-06-06 | Patel Anish (CHIEF OPERATING OFFICER) | Option Ex | 1,133 | 2.48 | 2,809 |
| 2024-05-29 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 12,000 | 22.04 | 264,516 |
| 2024-05-29 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Option Ex | 12,000 | 1.12 | 13,440 |
| 2024-05-28 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 12,000 | 23.59 | 283,104 |
| 2024-05-28 | Kintz Samuel (PRESIDENT AND CEO) | Option Ex | 12,000 | 1.12 | 13,440 |
| 2024-05-28 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 4,250 | 23.55 | 100,083 |
| 2024-05-28 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 4,250 | 2.48 | 10,540 |
| 2024-05-16 | Orbimed Genesis Gp Llc | Sale | 1,033,300 | 22.14 | 22,877,262 |
| 2024-05-16 | Heyman Richard A. | Sale | 1,270 | 23.74 | 30,149 |
| 2024-05-16 | Gupta Rishi | Sale | 1,033,300 | 22.14 | 22,877,262 |
| 2024-05-14 | Patel Anish (CHIEF OPERATING OFFICER) | Sale | 1,107 | 25.00 | 27,675 |
| 2024-05-14 | Patel Anish (CHIEF OPERATING OFFICER) | Option Ex | 1,107 | 2.48 | 2,745 |
| 2024-05-09 | Patel Anish (CHIEF OPERATING OFFICER) | Sale | 260 | 25.06 | 6,515 |
| 2024-05-09 | Patel Anish (CHIEF OPERATING OFFICER) | Option Ex | 260 | 2.48 | 644 |
| 2024-05-06 | Patel Anish (CHIEF OPERATING OFFICER) | Sale | 4,875 | 22.72 | 110,769 |
| 2024-05-06 | Patel Anish (CHIEF OPERATING OFFICER) | Option Ex | 4,875 | 2.48 | 12,090 |
| 2024-05-03 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 1,000 | 22.50 | 22,500 |
| 2024-05-03 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 1,000 | 2.48 | 2,480 |
| 2024-04-29 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Sale | 12,000 | 18.17 | 218,075 |
| 2024-04-29 | Lyssikatos Joseph P (CHIEF SCIENTIFIC OFFICER) | Option Ex | 12,000 | 1.12 | 13,440 |
| 2024-04-29 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Sale | 3,250 | 16.97 | 55,165 |
| 2024-04-29 | Hohl Benjamin (CHIEF FINANCIAL OFFICER) | Option Ex | 3,250 | 2.48 | 8,060 |
| 2024-04-25 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 12,000 | 16.89 | 202,704 |
| 2024-04-25 | Kintz Samuel (PRESIDENT AND CEO) | Option Ex | 12,000 | 1.12 | 13,440 |
| 2024-04-15 | Heyman Richard A. | Sale | 1,270 | 20.31 | 25,792 |
| 2024-04-11 | Kintz Samuel (PRESIDENT AND CEO) | Sale | 47,709 | 25.04 | 1,194,681 |
Insider trading activities including stock purchases, stock sales, and option exercises of ELVN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Enliven Therapeutics, Inc. (symbol ELVN, CIK number 1672619) see the Securities and Exchange Commission (SEC) website.